RSS Newsfeeds

See all RSS Newsfeeds

Apr 21, 2017 6:20 AM ET

Archived: -Global Tamoxifen Market to Reach $683.6 Million by 2022: Key Vendors are AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex & Midatech

iCrowdNewswire - Apr 21, 2017

M2 PRESSWIRE-April 21, 2017-Global Tamoxifen Market to Reach $683.6 Million by 2022: Key Vendors are AstraZaneca, Teva Pharmaceutical Industries, Allergan, Mylan, Apotex & Midatech


Dublin – Research and Markets has announced the addition of the “Global Tamoxifen Market – 2014 to 2022” report to their offering.

The tamoxifen market was valued at USD 675.7 Mn in 2015, and is expected to reach USD 683.6 Mn by 2022, expanding at a CAGR of 0.07% from 2016 to 2022.

Tamoxifen is the oldest and among the most prescribed selective estrogen receptor modulator for breast cancer treatment and management. Tamoxifen is approved for early stage, hormone receptor positive breast cancer in men and women, after surgery or chemotherapy to reduce recurrence risk, and for management of advanced stage or metastatic hormone-receptor positive breast cancer. Women at high risk of developing breast cancer also use Tamoxifen. Tamoxifen is at the maturity stage of product life cycle and is anticipated to experience decline in market growth in the light of introduction of advanced breast cancer management drugs.

This report analyzes the geographical distribution of tamoxifen market in North America, Europe, Asia-Pacific and Rest of the World markets. Currently, North America is the largest market for tamoxifen drugs and it is anticipated that the lead of this region will continue through 2022. Large pool of breast cancer patients, high awareness for breast cancer screening and prevention, well-structured reimbursement scenario and large pool of breast cancer patients. Asia-Pacific and Rest of the World markets will experience the fastest CAGR during 2016-2022. Improving awareness in Middle East and Africa, high incidence of late stage breast cancer in these regions and rapid development of healthcare infrastructure are the prime drivers of Rest of the World market.

Companies Mentioned

– Allergen plc
– Apotex, Inc
– Astra Zeneca plc
– Mylan Pharmaceuticals, Inc.
– Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 Tamoxifen: Market Dynamics and Outlook

Chapter 4 Global Tamoxifen Market, Pipeline Analysis

Chapter 5 Global Tamoxifen Market, by Geography

Chapter 6 Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/jn2423/global_tamoxifen

Contact Information:

Research and Markets,
Laura Wood,
Senior Manager.
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Related Topics: Breast Cancer Drugs (http://www.researchandmarkets.com/categories.asp?cat_id=207&campaign_id=jn2423)

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.m2.com on the world wide web. Inquiries to info@m2.com)).

Via iCrowdNewswire
Tags: , Wire, M2 Presswire
View Related News >